keyword
https://read.qxmd.com/read/38709693/beyond-the-label-real-world-side-effects-experienced-with-fda-approved-drugs-for-non-melanoma-skin-cancers
#1
JOURNAL ARTICLE
Advaitaa Ravipati, Tejus Pradeep, Keyvan Nouri
With immunotherapy historically focused on cutaneous melanoma, there has been a new wave of systemic medications available for treating non-melanoma skin cancers including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and Merkel cell carcinoma (MCC). The immune checkpoint inhibitors approved by the FDA target programmed cell death protein 1 (PD-1) and the Hedgehog (Hh) signaling pathway. These medications have expanded treatment options; however, side effects are an important consideration. We used the FDA Adverse Events Reporting System (FAERS) to characterize the most prevalent, real-world side effects experienced by patients on these agents...
May 1, 2024: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/38709540/noticing-voluntary-e-cigarette-warning-labels-and-associations-with-harm-perceptions-and-use-intentions-a-baseline-cross-sectional-analysis-of-wave-4-of-the-population-assessment-of-tobacco-and-health-study-prior-to-the-food-and-drug-administration-mandate
#2
JOURNAL ARTICLE
Christina N Wysota, Zongshuan Duan, Yan Wang, Raymond S Niaura, Lorien C Abroms
PURPOSE: To examine the effect of e-cigarette warning labels (EWLs) prior to the August 2018 FDA-warning label mandate to establish a baseline for future research. DESIGN: Cross-sectional survey. SETTING: United States. PARTICIPANTS: A cohort of adult participants in the Population Assessment of Tobacco and Health (PATH) study (n = 30,004) at Wave 4 (Dec 2016-Jan 2018). MEASURES: Correlates (e...
May 6, 2024: American Journal of Health Promotion: AJHP
https://read.qxmd.com/read/38709062/determination-of-continuity-index-values-in-atrial-fibrillation-ablation-with-proactive-esophageal-cooling
#3
JOURNAL ARTICLE
Catherine Lazarus, Jacob Sherman, Natalie Putzel, Tiffany Sharkoski, William Zagrodzky, Erik Kulstad, Alex Ro, Jose Nazari, Westby Fisher, Mark Metzl
Radiofrequency (RF) ablation to perform pulmonary vein isolation (PVI) for the treatment of atrial fibrillation involves some risk to collateral structures, including the esophagus. Proactive esophageal cooling using a dedicated device has been granted marketing authorization by the Food and Drug Administration (FDA) to reduce the risk of ablation-related esophageal injury due to RF cardiac ablation procedures, and more recent data also suggest that esophageal cooling may contribute to improved long-term efficacy of treatment...
April 19, 2024: Journal of Visualized Experiments: JoVE
https://read.qxmd.com/read/38708944/myosin-catalyzed-atp-hydrolysis-in-the-presence-of-disease-causing-mutations-mavacamten-as-a-way-to-repair-mechanism
#4
JOURNAL ARTICLE
Ananya Chakraborti, Jil C Tardiff, Steven D Schwartz
Hypertrophic cardiomyopathy is one of the most common forms of genetic cardiomyopathy. Mavacamten is a first-in-class myosin modulator that was identified via activity screening on the wild type, and it is FDA-approved for the treatment of obstructive hypertrophic cardiomyopathy (HCM). The drug selectively binds to the cardiac β-myosin, inhibiting myosin function to decrease cardiac contractility. Though the drug is thought to affect multiple steps of the myosin cross-bridge cycle, its detailed mechanism of action is still under investigation...
May 6, 2024: Journal of Physical Chemistry. B
https://read.qxmd.com/read/38708252/a-reliable-quantification-of-cholesterol-and-25-hydroxycholesterol-in-liposomal-adjuvant-formulation-by-liquid-chromatography-high-resolution-tandem-mass-spectrometry
#5
JOURNAL ARTICLE
Erwin G Abucayon, Scott Sweeney, Gary R Matyas
Cholesterol, as one of the major components of liposomes, plays a critical role in modulating membrane bilayer permeability, fluidity, and structural stability. Controlling these quality attributes is essential to maintaining the efficacy and fitness of the liposomes in various applications. However, during the manufacture and storage of liposomes, cholesterol has a propensity to undergo oxidative degradation. Hence, an analytical tool that is capable of determining not only the identity and quantity of cholesterol but also its associated degradants is a prerequisite to effective process control and product quality and safety assessments...
April 30, 2024: ACS Omega
https://read.qxmd.com/read/38708229/investigation-of-biogenic-amine-levels-and-microbiological-activity-as-quality-markers-in-some-dairy-and-fish-products-in-food-markets-in-the-kingdom-of-saudi-arabia
#6
JOURNAL ARTICLE
Mohammed Aladhadh, Dalal Nasser Binjawhar, Hafsa Nour El-Din Abd El-Kader Ebrahim, Khadija S Radhi, Manal Almatrafi, Eman Fayad, Mahmoud A Al-Saman, Rafaat M Elsanhoty
This study aimed to verify the presence of biogenic amines (BAs) and evaluate the microbiological activity of some food samples collected from retail stores in the Kingdom of Saudi Arabia. A total of thirty-five dairy and fish products were collected and analyzed for BAs, including putrescine (PUT), cadaverine (CAD), spermidine (SPE), histamine (HIS), spermine (SPR), and tyramine (TYR), as well as for total colony count (TCC), lactic acid bacteria (LAB), Enterobacteriaceae, yeast and mold (Y and M), coliforms, and aerobic sporulation count (ASF)...
April 30, 2024: ACS Omega
https://read.qxmd.com/read/38707869/reporting-of-demographics-subgroup-analyses-in-premarketing-studies-of-fda-approved-high-risk-cardiovascular-devices-2014-2022
#7
JOURNAL ARTICLE
Matthew J Swanson, Colin L Uyeki, Sarah R Yoder, Sanket S Dhruva, Jennifer E Miller, Joseph S Ross
BACKGROUND: Representation of diverse study populations in pivotal clinical trials for medical devices and subgroup analyses for demographic groups to explore differences in safety and effectiveness are essential to understanding the benefits and risks in diverse populations. The US Food and Drug Administration (FDA) has taken many steps to improve transparency and subgroup analyses over the past decade, but there has not been a recent evaluation of demographic reporting and subgroup analyses...
2024: Medical Devices: Evidence and Research
https://read.qxmd.com/read/38707469/advancements-in-sars-cov-2-detection-navigating-the-molecular-landscape-and-diagnostic-technologies
#8
REVIEW
Nuha Almulla, Raya Soltane, Ahlam Alasiri, Abdou Kamal Allayeh, Taha Alqadi, Fatma Alshehri, Ahlam Hamad Alrokban, Sameh S Zaghlool, Abdallah Z Zayan, Karam F Abdalla, Ahmed M Sayed
According to information from the World Health Organization, the world has experienced about 430 million cases of COVID-19, a world-wide health crisis caused by the SARS-CoV-2 virus. This outbreak, originating from China in 2019, has led to nearly 6 million deaths worldwide. As the number of confirmed infections continues to rise, the need for cutting-edge techniques that can detect SARS-CoV-2 infections early and accurately has become more critical. To address this, the Federal Drug Administration (FDA) has issued emergency use authorizations (EUAs) for a wide range of diagnostic tools...
May 15, 2024: Heliyon
https://read.qxmd.com/read/38707387/subtractive-genomics-study-for-the-identification-of-therapeutic-targets-against-cronobacter-sakazakii-a-threat-to-infants
#9
JOURNAL ARTICLE
Ishtiaque Ahammad, Anika Bushra Lamisa, Sadia Sharmin, Arittra Bhattacharjee, Zeshan Mahmud Chowdhury, Tanvir Ahamed, Mohammad Uzzal Hossain, Keshob Chandra Das, Md Salimullah, Chaman Ara Keya
Cronobacter sakazakii is an opportunistic pathogen that has been associated with severe infection in neonates such as necrotizing enterocolitis (NEC), neonatal meningitis, and bacteremia. This pathogen can survive in a relatively dry environment, especially in powdered infant formula (PIF). Unfortunately, conventional drugs that were once effective against C. sakazakii are gradually losing their efficacy due to rising antibiotic resistance. In this study, a subtractive genomic approach was followed in order to identify potential therapeutic targets in the pathogen...
May 15, 2024: Heliyon
https://read.qxmd.com/read/38706997/a-longitudinal-analysis-of-black-box-warnings-trends-and-implications-for-drug-safety
#10
REVIEW
Yazhini Rajendran, Nikhila Kondampati, Madhavi Eerike, Kalpana Mali, Leo Francis C
A black box warning, signaling potential life-threatening adverse effects of medications or medical devices, is crucial for public and healthcare professional awareness. Comprehending and adhering to these warnings can prevent serious harm. This review aims to elucidate their significance. Data on drugs with black box warnings were collected from the Food and Drug Administration's (FDA's) official website using the search term 'Boxed warnings' from January 1, 2015, to January 31, 2024. A Microsoft Excel spreadsheet (Microsoft Corporation, Redmond, WA, USA) containing black box warnings for this period was downloaded from the FDA's website...
April 2024: Curēus
https://read.qxmd.com/read/38706984/farnesol-repurposing-for-prevention-and-treatment-of-acinetobacter-baumannii-biofilms
#11
JOURNAL ARTICLE
Li Tan, Rong Ma, Adam J Katz, Nicole Levi
Acinetobacter baumannii has emerged as a multidrug-resistant (MDR) superbug by causing severe infections, with high mortality rates. The ability of A. baumannii to form biofilms significantly contributes to its persistence in diverse environmental and hospital settings. Here we report that farnesol, an FDA-approved commercial cosmetic and flavoring agent, demonstrates efficacy for both inhibition of biofilm formation, and disruption of established A. baumannii biofilms. Moreover, no resistance to farnesol was observed even after prolonged culture in the presence of sub-inhibitory farnesol doses...
June 2024: Biofilm
https://read.qxmd.com/read/38706731/insights-into-spheroids-formation-in-cellulose-nanofibrils-and-matrigel-hydrogels-using-afm-based-techniques
#12
JOURNAL ARTICLE
Roberta Teixeira Polez, Ngoc Huynh, Chris S Pridgeon, Juan José Valle-Delgado, Riina Harjumäki, Monika Österberg
The recent FDA decision to eliminate animal testing requirements emphasises the role of cell models, such as spheroids, as regulatory test alternatives for investigations of cellular behaviour, drug responses, and disease modelling. The influence of environment on spheroid formation are incompletely understood, leading to uncertainty in matrix selection for scaffold-based 3D culture. This study uses atomic force microscopy-based techniques to quantify cell adhesion to Matrigel and cellulose nanofibrils (CNF), and cell-cell adhesion forces, and their role in spheroid formation of hepatocellular carcinoma (HepG2) and induced pluripotent stem cells (iPS(IMR90)-4)...
June 2024: Materials today. Bio
https://read.qxmd.com/read/38706369/cahql-a-patient-reported-outcome-instrument-to-assess-health-related-quality-of-life-in-congenital-adrenal-hyperplasia
#13
JOURNAL ARTICLE
Myrto Eleni Flokas, Li Yang, Kimberly R Middleton, Sarah Kollender, Megan Parker, Charles Sukin, Rebecca Wood Persky, Deborah P Merke
CONTEXT: Measuring health-related quality of life (HRQoL) is a crucial aspect of evaluating health care outcomes. Patients with congenital adrenal hyperplasia (CAH) often self-report deficiencies in HRQoL. OBJECTIVE: The aim of our study was to develop a disease-specific patient reported outcome (PRO) instrument to evaluate the HRQoL of patients >16 years old with classic congenital adrenal hyperplasia (CAH). DESIGN, SETTING AND OUTCOMES: Following the FDA guidelines for developing PRO instruments, we developed a conceptual framework for the instrument...
May 6, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38705935/glucagon-like-peptide-1-analogs-activate-amp-kinase-leading-to-reversal-of-the-warburg-metabolic-switch-in-breast-cancer-cells
#14
JOURNAL ARTICLE
Hagai Ligumsky, Sharon Amir, Tamar Arbel Rubinstein, Kate Guion, Tali Scherf, Avraham Karasik, Ido Wolf, Tami Rubinek
Breast cancer (BC) is associated with type 2 diabetes mellitus (T2DM) and obesity. Glucagon-like peptide (GLP)-1 regulates post-prandial insulin secretion, satiety, and gastric emptying. Several GLP-1 analogs have been FDA-approved for the treatment of T2DM and obesity. Moreover, GLP-1 regulates various metabolic activities across different tissues by activating metabolic signaling pathways like adenosine monophosphate (AMP) activated protein kinase (AMPK), and AKT. Rewiring metabolic pathways is a recognized hallmark of cancer, regulated by several cancer-related pathways, including AKT and AMPK...
May 6, 2024: Medical Oncology
https://read.qxmd.com/read/38705416/environmental-implications-and-nanotechnological-advances-in-octocrylene-enriched-sunscreen-formulations-a-comprehensive-review
#15
REVIEW
Amol D Gholap, Sagar R Pardeshi, Navnath T Hatvate, Nilesh Dhorkule, Sadikali F Sayyad, Md Faiyazuddin, Mohammad Khalid
Ultraviolet (UV) radiation is a major contributor to skin aging, cancer, and other detrimental health effects. Sunscreens containing FDA-approved UV filters, like avobenzone, offer protection but suffer from photodegradation and potential phototoxicity. Encapsulation, antioxidants, and photostabilizers are strategies employed to combat these drawbacks. Octocrylene, an organic UV filter, utilizes nanotechnology to enhance sun protection factor (SPF). This review examines recent literature on octocrylene-enriched sunscreens, exploring the interplay between environmental impact, nanotechnological advancements, and clinical trial insights...
May 3, 2024: Chemosphere
https://read.qxmd.com/read/38705285/behavioral-therapies-targeting-reward-mechanisms-in-substance-use-disorders
#16
REVIEW
Margaret C Wardle, Heather E Webber, Jin H Yoon, Angela M Heads, Angela L Stotts, Scott D Lane, Joy M Schmitz
Behavioral therapies are considered best practices in the treatment of substance use disorders (SUD) and used as first-line approaches for SUDs without FDA-approved pharmacotherapies. Decades of research on the neuroscience of drug reward and addiction have informed the development of current leading behavioral therapies that, while differing in focus and technique, have in common the overarching goal of shifting reward responding away from drug and toward natural non-drug rewards. This review begins by describing key neurobiological processes of reward in addiction, followed by a description of how various behavioral therapies address specific reward processes...
May 3, 2024: Pharmacology, Biochemistry, and Behavior
https://read.qxmd.com/read/38705243/amateur-versus-professional-users-of-the-yo%C3%A2-home-sperm-test-an-assessment-of-usability
#17
JOURNAL ARTICLE
Natan Bar-Chama, Lev Rabinovitch, Stanton Honig
OBJECTIVES: To assess the accuracy of home-test use by a real-world / amateur user. METHODS: This multi-site study investigated whether amateur users could use the FDA cleared YO® Home Sperm Test to obtain accurate MSC results when compared to trained laboratory technicians. The qualitative motile sperm concentration (MSC) results of amateur and professional YO users were compared to each other as well as to the results of an established automated sperm quality analyzer (SQA-V above and below a 6m/mL MSC cut-off)...
May 3, 2024: Urology
https://read.qxmd.com/read/38705141/myocardial-infarction-in-chronic-myeloid-leukemia-results-from-nationwide-readmission-database
#18
JOURNAL ARTICLE
Elrazi A Ali, Neel Patel, Mazin Khalid, Rasha Kaddoura, Madhumathi Kalavar, Jacob Shani, Mohamed Yassin
Background and Objective Chronic myeloid leukemia (CML) is a hematological malignancy with an excellent prognostic outcome. After advancements in CML treatment and the introduction of different tyrosine kinase inhibitors (TKI), the life expectancy of CML patients has become equivalent to that of the general population. As a result, coronary artery disease is anticipated to be the leading cause of death among CML patients. Moreover, TKI use is associated with a risk of endothelial dysfunction, thrombosis, and cardiovascular events, including myocardial infarction...
May 3, 2024: Oncology
https://read.qxmd.com/read/38704515/challenges-and-lessons-learned-in-autologous-chimeric-antigen-receptor-t-cell-therapy-development-from-a-statistical-perspective
#19
JOURNAL ARTICLE
Daniel Li, Zhenzhen Xu, Shihua Wen, Revathi Ananthakrishnan, Yeonhee Kim, Khadija Rerhou Rantell, Patricia Anderson, James Whitmore, Alan Chiang
Chimeric antigen receptor (CAR) T-cell therapy is a human gene therapy product where T cells from a patient are genetically modified to enable them to recognize desired target antigen(s) more effectively. In recent years, promising antitumor activity has been seen with autologous CAR T cells. Since 2017, six CAR T-cell therapies for the treatment of hematological malignancies have been approved by the Food and Drug Administration (FDA). Despite the rapid progress of CAR T-cell therapies, considerable statistical challenges still exist for this category of products across all phases of clinical development that need to be addressed...
May 4, 2024: Therapeutic Innovation & Regulatory Science
https://read.qxmd.com/read/38703993/incorporation-of-immunotherapies-and-nanomedicine-to-better-normalize-angiogenesis-based-cancer-treatment
#20
REVIEW
Saade Abdalkareem Jasim, Irina M Farber, Sara Abdalrazzaq M Noraldeen, Pooja Bansal, Hashem O Alsaab, Bekhzod Abdullaev, Adnan Taan Alkhafaji, Ahmed Hussien Alawadi, Hamza Fadhel Hamzah, Bahira Abdulrazzaq Mohammed
Neoadjuvant targeting of tumor angiogenesis has been developed and approved for the treatment of malignant tumors. However, vascular disruption leads to tumor hypoxia, which exacerbates the treatment process and causes drug resistance. In addition, successful delivery of therapeutic agents and efficacy of radiotherapy require normal vascular networks and sufficient oxygen, which complete tumor vasculopathy hinders their efficacy. In view of this controversy, an optimal dose of FDA-approved anti-angiogenic agents and combination with other therapies, such as immunotherapy and the use of nanocarrier-mediated targeted therapy, could improve therapeutic regimens, reduce the need for administration of high doses of chemotherapeutic agents and subsequently reduce side effects...
May 2, 2024: Microvascular Research
keyword
keyword
47310
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.